Can very low ApoB levels be a problem?

While high ApoB levels increase cardiovascular risk, very low levels (below 60 mg/dL) can indicate malnutrition, liver disease, or genetic conditions. Most people should aim for ApoB levels under 90 mg/dL for optimal heart health.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding ApoB and Its Role in Your Body

Apolipoprotein B (ApoB) is a protein that acts as the structural backbone of several lipoproteins that carry cholesterol and fats through your bloodstream. Each particle of LDL (low-density lipoprotein), VLDL (very low-density lipoprotein), IDL (intermediate-density lipoprotein), and Lp(a) contains exactly one ApoB molecule, making it an excellent marker for counting the total number of potentially harmful cholesterol-carrying particles in your blood.

Unlike traditional cholesterol tests that measure the amount of cholesterol, ApoB testing counts the actual number of particles that can penetrate arterial walls and contribute to plaque formation. This makes ApoB a more accurate predictor of cardiovascular disease risk than LDL cholesterol alone. While much attention focuses on lowering high ApoB levels, having levels that are too low can also signal underlying health issues that deserve attention.

What Are Normal ApoB Levels?

Understanding what constitutes normal ApoB levels helps put very low readings into context. The optimal range varies based on your cardiovascular risk factors, but general guidelines suggest the following targets:

Symptoms by Severity of Low ApoB Levels

ApoB LevelClassificationCommon SymptomsClinical Significance
60-80 mg/dL60-80 mg/dLLow-normalUsually noneGenerally beneficial for cardiovascular health
50-59 mg/dL50-59 mg/dLVery lowMay have mild fatigue or digestive issuesWarrants investigation for underlying causes
40-49 mg/dL40-49 mg/dLExtremely lowFat malabsorption, vitamin deficienciesOften indicates liver disease or genetic disorder
Below 40 mg/dL<40 mg/dLSeverely lowSevere malabsorption, neurological symptomsRequires immediate medical evaluation

These ranges are general guidelines. Individual symptoms and significance may vary based on underlying conditions and overall health status.

  • For most adults: Less than 90 mg/dL
  • For those with cardiovascular disease or diabetes: Less than 80 mg/dL
  • For very high-risk individuals: Less than 65 mg/dL

While these targets focus on upper limits, the lower end of the normal range typically starts around 60 mg/dL. Levels below this threshold, particularly under 50 mg/dL, may warrant further investigation. Regular monitoring through comprehensive lipid testing can help you track your ApoB levels and understand your cardiovascular health status.

When Low ApoB Levels Become Concerning

Very low ApoB levels, typically defined as below 60 mg/dL and especially under 50 mg/dL, can indicate several underlying conditions. While having lower ApoB generally reduces cardiovascular risk, extremely low levels may signal problems with how your body produces, processes, or absorbs fats and proteins.

Genetic Conditions

Several rare genetic disorders can cause very low ApoB levels. Abetalipoproteinemia is a condition where the body cannot produce ApoB, leading to severe fat malabsorption and vitamin deficiencies. Hypobetalipoproteinemia, a less severe variant, results in reduced ApoB production. These conditions often present in childhood with symptoms like failure to thrive, fatty stools, and neurological problems due to fat-soluble vitamin deficiencies.

Liver Disease

Since the liver produces ApoB-containing lipoproteins, liver dysfunction can significantly reduce ApoB levels. Conditions such as cirrhosis, hepatitis, or severe liver damage impair the organ's ability to synthesize proteins, including ApoB. This reduction often accompanies other signs of liver dysfunction, such as elevated liver enzymes, jaundice, or abnormal clotting times.

Malnutrition and Malabsorption

Severe malnutrition or conditions that impair nutrient absorption can lead to very low ApoB levels. This includes eating disorders, inflammatory bowel diseases like Crohn's disease or ulcerative colitis, celiac disease, and pancreatic insufficiency. When the body lacks adequate protein and fat intake or cannot properly absorb these nutrients, ApoB production decreases accordingly.

Symptoms Associated with Very Low ApoB

The symptoms of very low ApoB often relate to the underlying cause rather than the low ApoB itself. However, since ApoB-containing lipoproteins transport fat-soluble vitamins (A, D, E, and K), deficiency symptoms may develop over time.

Common symptoms associated with conditions causing very low ApoB include:

  • Chronic diarrhea or fatty stools (steatorrhea)
  • Unexplained weight loss despite adequate food intake
  • Fatigue and weakness
  • Night blindness or vision problems (vitamin A deficiency)
  • Bone pain or fractures (vitamin D deficiency)
  • Easy bruising or bleeding (vitamin K deficiency)
  • Neurological symptoms like numbness, tingling, or coordination problems (vitamin E deficiency)
  • Growth delays in children

Health Implications of Very Low ApoB

While low ApoB levels generally indicate reduced cardiovascular risk, extremely low levels can have several health implications that extend beyond heart health. Understanding these potential consequences helps explain why balance is important, even with biomarkers typically associated with disease risk when elevated.

Nutrient Deficiencies

Fat-soluble vitamins require lipoproteins for transport throughout the body. When ApoB levels are very low, the body may struggle to distribute these essential nutrients effectively. This can lead to deficiencies even when dietary intake appears adequate. Vitamin E deficiency, in particular, can cause progressive neurological damage if left untreated, while vitamin D deficiency affects bone health and immune function.

Hormonal Imbalances

Cholesterol serves as a precursor for steroid hormone production, including sex hormones like testosterone and estrogen, as well as cortisol. Very low cholesterol levels associated with extremely low ApoB can potentially impact hormone synthesis, though this typically occurs only in severe cases. Monitoring hormone levels alongside lipid markers provides a more complete picture of metabolic health.

Cognitive Function

Some research suggests that extremely low cholesterol levels may be associated with mood disorders and cognitive issues, though the relationship remains controversial. The brain contains about 25% of the body's cholesterol, which plays crucial roles in neurotransmitter function and cell membrane integrity. While more research is needed, maintaining cholesterol levels within a healthy range rather than pursuing the lowest possible levels may support optimal brain function.

Diagnosing the Cause of Low ApoB

When very low ApoB levels are detected, healthcare providers typically conduct a comprehensive evaluation to identify the underlying cause. This process involves several steps and may include multiple types of testing to rule out various conditions.

The diagnostic workup often includes:

  • Complete lipid panel including total cholesterol, LDL, HDL, and triglycerides
  • Liver function tests to assess hepatic health
  • Nutritional assessments including albumin and prealbumin levels
  • Fat-soluble vitamin levels (A, D, E, K)
  • Inflammatory markers to check for bowel diseases
  • Genetic testing if hereditary conditions are suspected
  • Imaging studies of the liver or intestines if indicated

Your healthcare provider will also conduct a thorough medical history, asking about digestive symptoms, dietary habits, family history of lipid disorders, and any medications that might affect lipid metabolism. This comprehensive approach helps distinguish between genetic causes, acquired conditions, and lifestyle factors contributing to low ApoB levels.

Treatment Approaches for Very Low ApoB

Treatment for very low ApoB levels depends entirely on the underlying cause. Unlike high ApoB, where the goal is typically reduction through lifestyle changes and medications, managing low ApoB requires addressing the root condition causing the abnormality.

Nutritional Interventions

For malnutrition or malabsorption issues, treatment focuses on improving nutrient intake and absorption. This may include working with a registered dietitian to develop a meal plan that ensures adequate protein and healthy fat intake, supplementing with fat-soluble vitamins in forms that enhance absorption, using digestive enzymes if pancreatic insufficiency is present, and treating underlying gastrointestinal conditions that impair absorption.

Medical Management

When liver disease causes low ApoB, treatment targets the hepatic condition. This might involve antiviral medications for hepatitis, lifestyle modifications for fatty liver disease, or specialized care for cirrhosis. For genetic conditions like abetalipoproteinemia, treatment typically includes high-dose fat-soluble vitamin supplementation, dietary fat restriction, and regular monitoring for complications.

Lifestyle Modifications

Supporting overall health through lifestyle choices remains important regardless of the cause of low ApoB. This includes maintaining a balanced diet with adequate calories and nutrients, managing stress levels, getting regular but not excessive exercise, ensuring quality sleep, and avoiding factors that might worsen any underlying conditions.

Monitoring and Follow-Up Care

Regular monitoring is essential for individuals with very low ApoB levels to track treatment progress and prevent complications. The frequency and type of monitoring depend on the underlying cause and severity of the condition. Your healthcare provider will develop a personalized monitoring plan that may include periodic lipid panels to track ApoB and other markers, regular assessment of fat-soluble vitamin levels, liver function tests if hepatic disease is present, and nutritional status evaluations.

Long-term follow-up helps ensure that treatment remains effective and allows for early detection of any complications. This is particularly important for genetic conditions that may have progressive effects or for chronic diseases that require ongoing management. Regular testing provides the data needed to adjust treatment plans and optimize health outcomes.

The Bottom Line on Low ApoB Levels

While most discussions about ApoB focus on the cardiovascular risks of elevated levels, very low ApoB deserves attention as a potential indicator of underlying health issues. Levels below 60 mg/dL, and especially under 50 mg/dL, warrant investigation to rule out genetic conditions, liver disease, malnutrition, or malabsorption disorders.

The key is finding the right balance. For most people, maintaining ApoB levels below 90 mg/dL provides excellent cardiovascular protection without risking the potential complications of extremely low levels. If you discover your ApoB is very low, work with your healthcare provider to identify any underlying causes and develop an appropriate treatment plan.

Remember that ApoB is just one piece of your overall health picture. Comprehensive testing that includes multiple biomarkers provides the most complete understanding of your metabolic and cardiovascular health, allowing for personalized strategies to optimize your wellbeing while avoiding potential risks at both extremes of the ApoB spectrum.

References

  1. Sniderman, A. D., Thanassoulis, G., Glavinovic, T., Navar, A. M., Pencina, M., Catapano, A., & Ference, B. A. (2019). Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiology, 4(12), 1287-1295.[PubMed][DOI]
  2. Schonfeld, G., & Lin, X. (2019). Familial hypobetalipoproteinemia: genetics and metabolism. Cellular and Molecular Life Sciences, 76(8), 1541-1558.[PubMed][DOI]
  3. Welty, F. K. (2020). Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease. Current Opinion in Lipidology, 31(2), 49-55.[PubMed][DOI]
  4. Hooper, A. J., & Burnett, J. R. (2018). Update on primary hypobetalipoproteinemia. Current Atherosclerosis Reports, 20(5), 23.[PubMed][DOI]
  5. Tarugi, P., & Averna, M. (2011). Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum. Advances in Clinical Chemistry, 54, 81-107.[PubMed][DOI]
  6. Minicocci, I., Montali, A., Robciuc, M. R., Quagliarini, F., Censi, V., Labbadia, G., ... & Arca, M. (2012). Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization. Journal of Clinical Endocrinology & Metabolism, 97(7), E1266-E1275.[PubMed][DOI]

Frequently Asked Questions

How can I test my ApoB at home?

You can test your ApoB at home with SiPhox Health's Core Health Program, which includes ApoB testing along with 24 other essential biomarkers. The program offers convenient at-home blood collection with lab-quality results and personalized insights to help you understand and optimize your cardiovascular health.

What is considered a dangerously low ApoB level?

ApoB levels below 50 mg/dL are generally considered very low and may indicate an underlying health condition. Levels below 40 mg/dL are particularly concerning and almost always warrant immediate medical evaluation to rule out genetic disorders, severe malnutrition, or significant liver disease.

Can medications cause low ApoB levels?

While cholesterol-lowering medications like statins and PCSK9 inhibitors can significantly reduce ApoB levels, they rarely cause levels to drop below the normal range in people without underlying conditions. However, certain medications that affect liver function or nutrient absorption could potentially contribute to very low ApoB levels as a side effect.

Should I be worried if my ApoB is at the low end of normal?

If your ApoB is between 60-80 mg/dL and you have no symptoms or known health conditions, this is generally considered beneficial for cardiovascular health. However, if you experience unexplained weight loss, digestive issues, or vitamin deficiency symptoms, discuss these with your healthcare provider even if your ApoB is within the normal range.

How quickly can ApoB levels change?

ApoB levels can change within weeks to months depending on the cause. Nutritional changes or starting treatment for malabsorption may show improvements within 4-8 weeks. However, genetic conditions causing low ApoB are permanent and require ongoing management rather than correction of the ApoB level itself.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details